Lukebens answer is the simple one Shelby. Ofcourse it's more complicated, but for now it's the only option. But it's not the cause of our predicament. That is primarily a lack of production. If we were producing and profitable then we would either be self funding or atleast higher sp.
Higher sp means rights issue "could" be successful or the notes atleast convert at higher sp and get absorbed by market. Profit even opens up debt funding.
The reasons for lack of production are many. Lack of funds (catch 22). Poor due diligence (legal issues). Mismanagement (poor technical decisions in some insstances).
JV is still dilutive, ie losing 50% WI. But atleast their is no selling pressure attached. So that is still the ultimate goal for GGP. But nobody wants a piece of a lease about to expire and under legal threat. Clear one obsticle (the expiry) and that "may" change. Clear both obsticles and the "will" change.
- Forums
- ASX - By Stock
- GGP
- share consolidation
share consolidation, page-18
-
-
- There are more pages in this discussion • 58 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GGP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online